The clinical trial model is up for review: time, expense, and quality of results are at issue, as is the relationship to drug pricing.

Costly medications have raised questions about the role that long, complex clinical trials play in drug pricing. Approval of a drug takes, on average, 14 years, costs more than $2 billion, and has a high risk of failure. Participants are seeking alternatives.